화학공학소재연구정보센터
검색결과 : 93건
No. Article
71 Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma
Nomura F, Sogawa K, Noda K, Seimiya M, Matsushita K, Miura T, Tomonaga T, Yoshitomi H, Imazeki F, Takizawa H, Mogushi K, Miyazaki M, Yokosuka O
Biochemical and Biophysical Research Communications, 421(4), 837, 2012
72 CGK733 enhances multinucleated cell formation and cytotoxicity induced by taxol in Chk1-deficient HBV-positive hepatocellular carcinoma cells
Wang H, Zuo B, Wang HB, Ren LF, Yang P, Zeng M, Duan D, Liu C, Li MY
Biochemical and Biophysical Research Communications, 422(1), 103, 2012
73 Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance
Li JP, Wang YP, Yu WJ, Chen J, Luo JP
Biochemical and Biophysical Research Communications, 406(1), 70, 2011
74 Sequence polymorphisms of mitochondrial D-loop and hepatocellular carcinoma outcome
Wang CJ, Zhang FB, Fan HY, Peng L, Zhang RX, Liu SF, Guo ZJ
Biochemical and Biophysical Research Communications, 406(3), 493, 2011
75 The human LIS1 is downregulated in hepatocellular carcinoma and plays a tumor suppressor function
Xing Z, Tang X, Gao Y, Da L, Song H, Wang SQ, Tiollais P, Li TP, Zhao MJ
Biochemical and Biophysical Research Communications, 409(2), 193, 2011
76 miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma
Wang CM, Wang Y, Fan CG, Xu FF, Sun WS, Liu YG, Jia JH
Biochemical and Biophysical Research Communications, 411(3), 586, 2011
77 miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines
Henry JC, Park JK, Jiang JM, Kim JH, Nagorney DM, Roberts LR, Banerjee S, Schmittgen TD
Biochemical and Biophysical Research Communications, 403(1), 120, 2010
78 Reexpression of ARHI inhibits tumor growth and angiogenesis and impairs the mTOR/VEGF pathway in hepatocellular carcinoma
Zhao XH, Li JF, Zhuo JX, Cai LX
Biochemical and Biophysical Research Communications, 403(3-4), 417, 2010
79 Polymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseases
Li LJ, Wang HY, Ong ZY, Xu KJ, Ee PLR, Zheng SS, Hedrick JL, Yang YY
Nano Today, 5(4), 296, 2010
80 Ablation of phosphoinositide-3-kinase class II alpha suppresses hepatoma cell proliferation
Ng SKL, Neo SY, Yap YW, Karuturi RKM, Loh ESL, Liau KH, Ren EC
Biochemical and Biophysical Research Communications, 387(2), 310, 2009